CLINUVEL PHARMACEUTICALS/ AU000000CUV3 /
2024-03-28 8:02:04 AM | Chg. -0.0200 | Volume | Bid9:48:06 AM | Ask9:48:06 AM | High | Low |
---|---|---|---|---|---|---|
8.5800EUR | -0.23% | 0 Turnover: 0.0000 |
8.5980Bid Size: 240 | 8.6860Ask Size: 240 | 8.5800 | 8.5800 |
GlobeNewswire
9:25 AM
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
GlobeNewswire
2018-12-19
Phase II study: SCENESSE® in combination with narrowband ultraviolet B (NB-UVB) achieves repigmentat...
GlobeNewswire
2018-06-25
FDA to Review Australian Drug for Genetic Disorder of Absolute Light Intolerance
GlobeNewswire
2017-04-12
CLINUVEL reaches agreement on German SCENESSE® pricing through AMNOG Arbitration Board
GlobeNewswire
2016-06-01
Nasdaq Welcomes Additional Companies to the Nasdaq International Designation